Zentalis Pharmaceuticals, Inc. (ZNTL) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Zentalis Pharmaceuticals, Inc. (ZNTL) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

ZNTL Income Statement

Zentalis Pharmaceuticals, Inc. (ZNTL) annual income statement — 8-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	26.86M	0	0	40.56M	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-100%	-	-	-100%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	151K	0	0	0	0	0	0	0	324K	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	0.8%	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-151K	0	0	0	0	26.86M	0	0	40.24M	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	100%	-	-	99.2%	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-100%	-	-	-100%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	82.25M	37.7M	37.39M	33.73M	36.06M	45.62M	76.71M	51.43M	65.15M	65M	67.92M	62.72M	103.92M	64.95M	51.75M	54.19M	63.46M	57.88M	48.19M	62.87M
OpEx % of Revenue	-	-	-	-	-	-	285.55%	-	-	160.26%	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	18.37M	8.99M	7.91M	10.78M	7.3M	10.58M	40.01M	14.61M	16.76M	15.42M	16.36M	15.95M	15.66M	16.37M	11.14M	12.01M	19.64M	11.77M	9.75M	8.87M
SG&A % of Revenue	-	-	-	-	-	-	148.91%	-	-	38.01%	-	-	-	-	-	-	-	-	-	-
Research & Development	63.88M	28.72M	29.49M	22.95M	27.61M	27.25M	32.97M	36.82M	48.39M	49.59M	51.56M	46.77M	42.68M	48.58M	40.62M	42.18M	43.83M	46.11M	38.44M	54M
R&D % of Revenue	-	-	-	-	-	-	122.74%	-	-	122.25%	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	1000K	1000K	1000K	0	-1	0	1	0	1000K	0	0	0	0	0	0	0
Operating Income	-82.25M	-37.85M	-37.39M	-33.73M	-36.06M	-45.62M	-49.85M	-51.43M	-65.15M	-24.77M	-67.92M	-62.72M	-103.92M	-64.95M	-51.75M	-54.19M	-63.46M	-57.88M	-48.19M	-62.87M
Operating Margin %	-	-	-	-	-	-	-185.55%	-	-	-61.06%	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-128.09%	17.03%	24.99%	34.41%	44.65%	-84.22%	26.61%	17.99%	37.31%	61.87%	-31.24%	-15.73%	-63.75%	-12.22%	-7.39%	13.8%	-15.11%	-14.96%	-19.75%	-80.83%
EBITDA	-82.09M	-37.7M	-37.24M	-33.57M	-35.9M	-45.36M	-49.53M	-51.11M	-64.82M	-24.44M	-67.58M	-62.37M	-103.57M	-64.59M	-51.4M	-53.82M	-63.11M	-57.53M	-47.98M	-62.73M
EBITDA Margin %	-	-	-	-	-	-	-184.37%	-	-	-60.26%	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-128.68%	16.88%	24.82%	34.31%	44.62%	-85.59%	26.71%	18.05%	37.41%	62.16%	-31.5%	-15.89%	-64.11%	-12.27%	-7.11%	14.21%	-14.72%	-14.46%	-19.33%	-80.7%
D&A (Non-Cash Add-back)	153K	151K	157K	160K	160K	262K	317K	321K	327K	324K	337K	348K	344K	360K	359K	375K	348K	344K	209K	137K
EBIT	-77.38M	-35.23M	-34.77M	-26.69M	-34.91M	-37.83M	-46.11M	-40.19M	-88.01M	10.18M	-61.07M	-62.72M	-58.35M	-64.95M	-51.75M	-54.19M	-63.46M	-57.88M	-38.19M	-62.87M
Net Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-344.51K	0	0	0	0	0
Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	493	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	345K	0	0	0	0	0
Other Income/Expense	4.87M	2.62M	2.62M	7.04M	9.18M	-2.66M	2.17M	11.25M	-22.86M	34.95M	6.85M	7.21M	-9.25M	1.8M	-3.59M	-466K	-4.91M	-1.32M	-1.74M	51.68M
Pretax Income	-77.38M	-35.23M	-34.77M	-26.69M	-26.87M	-48.28M	-47.68M	-40.19M	-88.01M	10.18M	-61.07M	-55.51M	-113.17M	-63.15M	-55.34M	-54.66M	-68.38M	-59.2M	-49.94M	-11.19M
Pretax Margin %	-	-	-	-	-	-	-177.47%	-	-	25.11%	-	-	-	-	-	-	-	-	-	-
Income Tax	258K	120K	442K	0	0	0	-205K	-27K	266K	143K	-135K	31K	-605K	108K	-360K	-159K	17K	33K	159K	-697K
Effective Tax Rate %	-0.33%	-0.34%	-1.27%	0%	0%	0%	0.43%	0.07%	-0.3%	1.4%	0.22%	-0.06%	0.53%	-0.17%	0.65%	0.29%	-0.02%	-0.06%	-0.32%	6.23%
Net Income	-77.64M	-35.35M	-35.22M	-26.69M	-26.87M	-48.28M	-47.47M	-40.16M	-88.28M	10.07M	-60.92M	-55.53M	-112.53M	-63.22M	-54.97M	-54.4M	-68.36M	-59.08M	-50.06M	-4.19M
Net Margin %	-	-	-	-	-	-	-176.71%	-	-	24.82%	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-188.9%	26.78%	25.82%	33.53%	69.56%	-579.53%	22.07%	27.68%	21.55%	115.93%	-10.82%	-2.07%	-64.62%	-7.01%	-9.81%	-1198.04%	-25.26%	-18.39%	-24.21%	87.87%
Net Income (Continuing)	-77.64M	-35.35M	-35.22M	-26.69M	-26.87M	-48.28M	-47.47M	-40.16M	-88.28M	10.04M	-60.94M	-55.54M	-112.56M	-63.26M	-54.98M	-54.5M	-68.39M	-59.24M	-50.09M	-10.49M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	107K	129K	141K	178K	221K	234K	333K	368K	528K	564K
EPS (Diluted)	-1.10	-0.50	-0.49	-0.37	-0.37	-0.67	-0.67	-0.56	-1.24	0.14	-0.86	-0.79	-1.85	-1.03	-0.81	-0.92	-1.23	-1.27	-1.11	-0.09
EPS Growth %	-197.3%	25.37%	26.87%	33.93%	70.16%	-578.57%	22.09%	29.11%	32.97%	113.59%	-6.17%	14.13%	-50.41%	18.9%	27.03%	-879.77%	8.21%	-2.42%	-9.9%	89.68%
EPS (Basic)	-1.10	-0.50	-0.49	-0.37	-0.37	-0.67	-0.67	-0.56	-1.24	0.14	-0.86	-0.79	-1.85	-1.03	-0.81	-0.92	-1.23	-1.27	-1.11	-0.09
Diluted Shares Outstanding	70.26M	70.26M	71.67M	72.14M	71.99M	71.68M	71.24M	71.11M	71.04M	71.19M	70.77M	70.61M	60.79M	59.28M	59.28M	56.81M	51.12M	45.24M	44.98M	44.61M
Basic Shares Outstanding	70.26M	70.26M	71.67M	72.14M	71.99M	71.68M	71.24M	71.11M	71.04M	70.9M	70.77M	70.61M	60.79M	59.28M	59.28M	56.81M	51.12M	45.24M	44.98M	44.61M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-